Exane Derivatives Constellation Brands, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Constellation Brands, Inc. stock. As of the latest transaction made, Exane Derivatives holds 160 shares of STZ stock, worth $36,420. This represents 0.02% of its overall portfolio holdings.
Number of Shares
160
Previous 163
1.84%
Holding current value
$36,420
Previous $37,000
-0.0%
% of portfolio
0.02%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding STZ
# of Institutions
1,477Shares Held
143MCall Options Held
1.29MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA13.7MShares$3.12 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$2.37 Billion0.06% of portfolio
-
Capital International Investors Los Angeles, CA10.2MShares$2.32 Billion0.52% of portfolio
-
Capital World Investors Los Angeles, CA9.43MShares$2.15 Billion0.39% of portfolio
-
Morgan Stanley New York, NY8.51MShares$1.94 Billion0.16% of portfolio
About CONSTELLATION BRANDS, INC.
- Ticker STZ
- Exchange NYSE
- Sector Consumer Defensive
- Industry Beverages—Wineries & Distilleries
- Shares Outstandng 161,224,000
- Market Cap $36.7B
- Description
- Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. It provides beer primarily under the Corona Extra, Corona Premier, Corona Familiar, Corona Light, Corona Refresca, Corona Hard Seltzer, Modelo Especial, Modelo Neg...